Cargando…
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients—Lessons Learned From SARS and MERS
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic keeps the world in suspense. In addition to the fundamental challenges for the health care system, the individual departments must decide how to deal with patients at risk. Neurologists are confronted with the question, how they s...
Autores principales: | Möhn, Nora, Pul, Refik, Kleinschnitz, Christoph, Prüss, Harald, Witte, Torsten, Stangel, Martin, Skripuletz, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235419/ https://www.ncbi.nlm.nih.gov/pubmed/32477373 http://dx.doi.org/10.3389/fimmu.2020.01059 |
Ejemplares similares
-
Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
por: Möhn, Nora, et al.
Publicado: (2020) -
Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis
por: Yildiz, Özlem, et al.
Publicado: (2015) -
The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2018) -
Neuroimmunologie von COVID‑19
por: Skripuletz, Thomas, et al.
Publicado: (2021) -
Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2017)